Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma

被引:1
|
作者
Liu, Baiyi [1 ]
Wang, Xiaoxiao [1 ]
Wu, Nan [1 ]
Liu, Feng [1 ]
Rao, Huiying [1 ]
机构
[1] Peking Univ Peoples Hosp, Peking Univ Hepatol Inst, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing Int Cooperat Base Sci & Technol NAFLD Diag, Beijing, Peoples R China
关键词
Nonalcoholic fatty liver disease (NAFLD); hepatocellular carcinoma (HCC); biomarkers; progression; prognosis; FIBROSIS STAGE; INFLAMMATION; VERSICAN; CELLS; NASH; STEATOHEPATITIS; PREVALENCE; PLATELETS; APOPTOSIS; PROTEIN;
D O I
10.2174/0109298673288887240212065116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. With an increasing number of patients, NAFLD has been identified as a risk factor for Hepatocellular Carcinoma (HCC). The precise pathophysiology of NAFLD-related HCC has not been completely understood recently.Objective We analyzed the hub genes related to NAFLD and HCC to predict the risk of NAFLD progressing to HCC.Methods Two datasets of NAFLD were used to identify differentially expressed genes. Lasso-Cox regression analysis was performed to determine a gene model to predict the risk of the progression from NAFLD to HCC. Three validation datasets were analyzed to evaluate the performance of the gene model, including normal and NAFLD with fibrosis, NAFLD with fibrosis and NAFLD-related HCC, and normal and NASH-related HCC.Results Seven genes, including COL1A1, TIPM1, VCAN, FOS, CD79A, CXCL9, and VWF, were identified as the hub genes, and then a gene model was constructed. By calculating, the area under the receiver operating characteristic curves (AUCs) for risk prediction were 0.97, 0.886, and 0.751 in the three validation datasets, respectively. Gene set enrichment analysis indicated that the MAPK, TGF beta, p53, PPAR, insulin signaling pathways, and fatty acid metabolism were significantly upregulated in the high-risk group. GTPase activity and intrinsic apoptotic signaling pathway had significant upregulation in the low-risk group.Conclusion The seven hub genes may predict the risk of NAFLD developing into HCC by mediating the potential molecular mechanism, which could be used as biomarkers for predicting the progression, diagnosis, and treatment of NAFLD.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Nonalcoholic fatty liver disease and hepatocellular carcinoma
    Zoller, Heinz
    Tilg, Herbert
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1151 - 1160
  • [2] Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Kikuchi, Luciana
    Oliveira, Claudia P.
    Carrilho, Flair J.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Inayat, Faisal
    Rahman, Zia Ur
    Hurairah, Abu
    CUREUS, 2016, 8 (08):
  • [4] Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Zhao, Lei
    Dong, Fei
    Tsai, Harrison
    Hornick, Jason
    Goyal, Lipika
    Hashemi, Nikroo
    Corey, Kathleen
    Misdraji, Joseph
    MODERN PATHOLOGY, 2019, 32
  • [5] Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Zhao, Lei
    Dong, Fei
    Tsai, Harrison
    Hornick, Jason
    Goyal, Lipika
    Hashemi, Nikroo
    Corey, Kathleen
    Misdraji, Joseph
    LABORATORY INVESTIGATION, 2019, 99
  • [6] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Massoud, Omar
    Charlton, Michael
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 201 - +
  • [7] Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
    Wang, Siyuan
    Li, Yiling
    Liu, Ning
    Shen, Wei
    Xu, Wenhao
    Yao, Peng
    GENETICS RESEARCH, 2022, 2022
  • [8] Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation
    Tilg, Herbert
    Moschen, Alexander
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (04): : 391 - 396
  • [9] Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
    Sumida, Yoshio
    Yoneda, Masashi
    Seko, Yuya
    Ishiba, Hiroshi
    Hara, Tasuku
    Toyoda, Hidenori
    Yasuda, Satoshi
    Kumada, Takashi
    Hayashi, Hideki
    Kobayashi, Takashi
    Imajo, Kento
    Yoneda, Masato
    Tada, Toshifumi
    Kawaguchi, Takumi
    Eguchi, Yuichiro
    Oeda, Satoshi
    Takahashi, Hirokazu
    Tomita, Eiichi
    Okanoue, Takeshi
    Nakajima, Atsushi
    DIAGNOSTICS, 2020, 10 (08)
  • [10] Role of nonalcoholic fatty liver disease in hepatocellular carcinoma
    Chavez-Tapia, Norberto C.
    Mendez-Sanchez, Nahum
    Uribe, Misael
    ANNALS OF HEPATOLOGY, 2009, 8 : S34 - S39